Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy.

about

Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant.

P2860

Q47396264-41088FFA-DE28-4BD9-A62E-5A8CEC4E645C

P2860

Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy.

Item

http://www.wikidata.org/entity/Q40187310

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Successful treatment of post-s ...... lozane/tazobactam monotherapy.

@en

type

Item

label

Successful treatment of post-s ...... lozane/tazobactam monotherapy.

@en

prefLabel

Successful treatment of post-s ...... lozane/tazobactam monotherapy.

@en

P1476

Successful treatment of post-s ...... lozane/tazobactam monotherapy.

@en

P2093

Alberto Enrico Maraolo

http://www.w3.org/2001/XMLSchema#string

Federico De Zottis

http://www.w3.org/2001/XMLSchema#string

Gianfranco Di Renzo

http://www.w3.org/2001/XMLSchema#string

Guglielmo Borgia

http://www.w3.org/2001/XMLSchema#string

Ivan Gentile

http://www.w3.org/2001/XMLSchema#string

P2860

Systemic antibiotic therapy for chronic osteomyelitis in adults

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli.

Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.

Monotherapy or combination therapy? The Pseudomonas aeruginosa conundrum.

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15).

What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?

P304

2678-2679

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKX172

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Riccardo Scotto

Antonio Riccardo Buonomo

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28575437

http://www.w3.org/2001/XMLSchema#string

Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy.

about

P2860

P2860

Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698